In final diagnostics guidance published today NICE has recommended that further research is carried out on 3 promising new blood tests for speeding up the identification of bloodstream bacteria and fungi in people with suspected bloodstream infections.
10 February 2016
The best way to diagnose, treat and monitor myeloma – a type of blood cancer – has been set out in guidance published today by the National Institute for Health and Care Excellence (NICE). The NICE clinical guideline aims to help the NHS provide consistently excellent care for people over the age of 16 in England with myeloma.
10 February 2016
NICE – the National Institute for Health and Care Excellence – has published guidance which will help us all to enjoy the sunshine safely.
09 February 2016
NICE has published draft guidance not recommending alirocumab (Praluent, Sanofi/Regeneron) as an option for people with high cholesterol (primary hypercholesterolaemia - heterozygous-familial and non-familial) and mixed dyslipidaemia.
08 February 2016
NICE – the National Institute for Health and Care Excellence – is consulting on potential new indicators for the NICE indicator menu. Indicators encourage health professionals to assess patients on a range of key health issues where diagnosis and treatment is supported by evidence-based guidelines. The aim is to tackle widespread public health challenges one patient at a time.
01 February 2016
NICE – the National Institute for Health and Care Excellence – is consulting on draft recommendations for the diagnosis and management of the blood cancer non-Hodgkin's lymphoma in adults and young people.
29 January 2016
0300 323 0142
(this number rings all our phones and is the best number to contact us on 9:00 – 17:30 Mon - Fri)
(out of office hours number)
Press releases are usually issued under embargo on the day before they are published on the website. If you are a journalist and would like to be added to our mailing list, please contact a member of the team.